TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
DRTS

Alpha Tau Medical Ltd

Healthcare · Biotechnology

15.50$ +3.0% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Alpha Tau Medical Ltd (DRTS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 69.3% of the shares are freely tradable; institutional investors hold 4.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 4.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 31.2%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 69.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 4.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 93Mio.

Largest Shareholders

Institutions

Institutions DRTS
Name Stake (%) Shares Change (%) Date
Gem Investment Advisors, LLC 1.55 1,434,476 +1,161.2 06/30/2026
HighTower Advisors, LLC 0.95 874,994 +27.4 03/31/2026
Aquamarine Financial (Cayman) Ltd 0.78 721,501 +0.0 06/30/2026
Pier Capital, LLC 0.75 691,939 +0.0 06/30/2026
Apella Capital, LLC 0.41 382,284 +0.0 06/30/2026
ARK Investment Management LLC 0.32 292,134 +0.0 03/31/2026
UBS Group AG 0.31 286,688 +1,285.0 03/31/2026

Funds

Funds DRTS
Name Stake (%) Shares Change (%) Date
iShares Core MSCI EAFE ETF 0.50 464,448 +0.0 08/31/2026
SEB Nordamerikafond Småbolag 0.30 275,000 +9.5 07/31/2026
Pier Capital Small Cap Growth Equity 0.27 247,522 -60.1 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings DRTS
Person Role Shares Value As of Type
Levy Raphi Chief Financial Officer 90,180 1,397,790 $ Aug 21, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 21, 2026 Levy Raphi Chief Financial Officer Sell 2,871 15.00 43,073
Aug 21, 2026 Levy Raphi Chief Financial Officer Other 2,871 2.98 8,556
Aug 11, 2026 Levy Raphi Chief Financial Officer Sell 17,730 14.00 248,277
Aug 11, 2026 Levy Raphi Chief Financial Officer Other 17,730 2.98 52,835

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?